The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
|Slideshows|July 1, 2021
Fourth of July 2021: What are Americans Planning?
Author(s)Sydney Jennings
Advertisement
Awe-inspiring firework displays, parades, cookouts, beach trips—these are all treasured Fourth of July celebrations that were significantly restrained last year due to the COVID-19 pandemic. However, as more Americans are becoming fully vaccinated and states are loosening public health restrictions, will this Fourth of July be better? Two new surveys of US adults aimed to find out.
The first was a nationally representative survey of approximatively 650 adults between June 7, 2021 and June 11, 2021, conducted by
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement